HYDERABAD: Jiangsu Recbio Technology Co. Ltd, a leading Chinese biopharmaceutical firm, has entered into a licensing and ...

Biological E Ltd. has partnered with Jiangsu Recbio Technology to commercialize the latter's HPV9 vaccine, REC603, in India.

BE to produce and commercialise Recbio's nine-valent HPV vaccine in India and global markets, including participation in ...

Biological E. to produce Recbio's HPV9 vaccine in India, expanding global access to cervical cancer prevention.

According to the agreement, BE will receive the exclusive right to commercialise the vaccine in India and participate in ...

Biological E partners with China’s Recbio to produce REC603 a 9-valent HPV vaccine in India The collaboration aims to expand ...

Jiangsu Recbio Technology Company Limited, a leading Chinese biopharmaceutical company, today announced they have entered into a licensing cooperation agreement, and commenced the technology transfer ...

Biological E Ltd. has partnered with Jiangsu Recbio Technology to commercialize the latter's HPV9 vaccine, REC603, in India. Recbio will supply the drug substance and technology for formulation ...

China-based Jiangsu Recbio Technology Company has entered into a licensing cooperation agreement with Biological E (BE) for technology transfer of its Recombinant 9-valent HPV (HPV9) vaccine. HPV ...

Biological E will begin large-scale manufacturing of the HPV9 vaccine once the Technology transfer is completed.